RYTHM, Inc.
Regulated industryTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $11.83
- 52-Week Range
- $10.15 – $50.38
- Market Cap
- $22.13M
- P/E (TTM)
- —
- EPS (TTM)
- -5.08
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 0.53
- PEG Ratio
- —
- Return on Equity
- 25.82%
- Return on Assets
- -2.36%
- Gross Margin
- 78.12%
- Operating Margin
- -6.65%
- Profit Margin
- 9.84%
- Current Ratio
- 0.64
- Debt/Equity
- 1.92
- Total Debt
- $80.62M
- Free Cash Flow
- $6.24M
- Revenue Growth
- 490.10%
- Earnings Growth
- —
- Enterprise Value
- $58.17M
Market Snapshot
About
RYTHM, Inc. is a healthcare technology company developing digital therapeutics and neurotechnology solutions. The company focuses on non-invasive treatments for neurological conditions and sleep disorders. RYTHM combines hardware devices with software platforms to deliver personalized therapeutic interventions.